These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 1992862)
21. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study. Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122 [TBL] [Abstract][Full Text] [Related]
22. Lipid peroxidation products and changes in phospholipid composition induced by indobufen in diabetic platelets. Dmoszyńska A; Walter-Croneck A; Ledwozyw A Thromb Res; 1995 Sep; 79(5-6):483-90. PubMed ID: 7502274 [TBL] [Abstract][Full Text] [Related]
23. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis]. Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347 [TBL] [Abstract][Full Text] [Related]
25. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen]. Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658 [TBL] [Abstract][Full Text] [Related]
26. Indobufen in secondary prevention of transient ischaemic attack. Multicentre Ischaemic Attack Study Group. Rogan J J Int Med Res; 1990; 18(3):240-4. PubMed ID: 2193837 [TBL] [Abstract][Full Text] [Related]
27. Comparison of aspirin and indobufen in healthy volunteers. Lee JY; Sung KC; Choi HI Platelets; 2016; 27(2):105-9. PubMed ID: 26083594 [TBL] [Abstract][Full Text] [Related]
28. The effect of indobufen on the thrombogenic potential of a Dacron prosthesis in an artificial circulation. Sheehan SJ; Monson JR; Salter MC; Rajah DS; Rajah SM; Kester RC Eur J Vasc Surg; 1988 Aug; 2(4):223-7. PubMed ID: 2975227 [TBL] [Abstract][Full Text] [Related]
29. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990 [TBL] [Abstract][Full Text] [Related]
30. Indobufen versus placebo in the prevention of restenosis after carotid endarterectomy: a double-blind pilot study. Pratesi C; Pulli R; Milanesi G; Lavezzari M; Pamparana F; Bertini D J Int Med Res; 1991; 19(3):202-9. PubMed ID: 1936509 [TBL] [Abstract][Full Text] [Related]
31. Prevention of recurrent deep venous thrombosis with indobufen. A 3-year follow-up study using color duplex scanning. Belcaro G; Errichi BM; De Simone P Angiology; 1993 Apr; 44(4):328-31. PubMed ID: 8457085 [TBL] [Abstract][Full Text] [Related]
32. Prophylaxis of recurrent deep venous thrombosis. A randomized, prospective study using indobufen and graduated elastic compression stockings. Belcaro G; Laurora G; Cesarone MR; De Sanctis MT Angiology; 1993 Sep; 44(9):695-9. PubMed ID: 8357095 [TBL] [Abstract][Full Text] [Related]
33. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up. Delis KT; Nicolaides AN; Wolfe JH; Stansby G J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272 [TBL] [Abstract][Full Text] [Related]
34. Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach. Carrieri P; Orefice G; La Pia S; Indaco A; D'Acunio F; Iadevaia V Pharmatherapeutica; 1983; 3(6):410-6. PubMed ID: 6353432 [TBL] [Abstract][Full Text] [Related]
35. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication. Mangiafico RA; Messina R; Attinà T; Dell'Arte S; Giuliano L; Malatino LS Angiology; 2000 Jun; 51(6):441-9. PubMed ID: 10870853 [TBL] [Abstract][Full Text] [Related]
36. Left ventricular thrombi: changes in size and in platelet deposition during treatment with indobufen and ticlopidine. Bellotti P; Claudiani F; Chiarella F; Domenicucci S; Scopinaro G; Mazzotta G; Lupi G; Strada P; Vecchio C Cardiology; 1990; 77(4):272-9. PubMed ID: 2073644 [TBL] [Abstract][Full Text] [Related]
37. Endoscopic evaluation of the effects of indobufen and aspirin in healthy volunteers. Marzo A; Crestani S; Fumagalli I; Giusti A; Lowenthal DT Am J Ther; 2004; 11(2):98-102. PubMed ID: 14999361 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Treat-Jacobson D; Bronas UG; Leon AS Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669 [TBL] [Abstract][Full Text] [Related]
39. A long-term study of policosanol in the treatment of intermittent claudication. Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084 [TBL] [Abstract][Full Text] [Related]
40. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study. Gresele P; Migliacci R; Di Sante G; Nenci GG; Vasc Med; 2000; 5(2):83-9. PubMed ID: 10943584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]